These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7775883)

  • 1. Epidemiological evaluation of oral polio vaccine efficacy in Cairo.
    Kotb MM; Shouman AE; Mortagy A
    J Egypt Public Health Assoc; 1993; 68(5-6):617-25. PubMed ID: 7775883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of oral polio vaccination against paralytic poliomyelitis: a matched case-control study in Somalia.
    Mahamud A; Kamadjeu R; Webeck J; Mbaeyi C; Baranyikwa MT; Birungi J; Nurbile Y; Ehrhardt D; Shukla H; Chatterjee A; Mulugeta A
    J Infect Dis; 2014 Nov; 210 Suppl 1():S187-93. PubMed ID: 25316835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of oral poliovirus vaccine in rural communities of North Arcot District, India.
    Balraj V; John TJ; Thomas M; Mukundan S
    Int J Epidemiol; 1990 Sep; 19(3):711-4. PubMed ID: 2262269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.
    Sutter RW; Prevots DR; Cochi SL
    Pediatr Clin North Am; 2000 Apr; 47(2):287-308. PubMed ID: 10761505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.
    Khan MM; Sharma S; Tripathi B; Alvarez FP
    Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine-using countries.
    Wkly Epidemiol Rec; 2003 Jul; 78(28):241-50. PubMed ID: 15571166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine policy changes and epidemiology of poliomyelitis in the United States.
    Alexander LN; Seward JF; Santibanez TA; Pallansch MA; Kew OM; Prevots DR; Strebel PM; Cono J; Wharton M; Orenstein WA; Sutter RW
    JAMA; 2004 Oct; 292(14):1696-701. PubMed ID: 15479934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemic poliomyelitis in The Gambia following the control of poliomyelitis as an endemic disease. II. Clinical efficacy of trivalent oral polio vaccine.
    Deming MS; Jaiteh KO; Otten MW; Flagg EW; Jallow M; Cham M; Brogan D; N'jie H
    Am J Epidemiol; 1992 Feb; 135(4):393-408. PubMed ID: 1550091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Prevots DR; Burr RK; Sutter RW; Murphy TV;
    MMWR Recomm Rep; 2000 May; 49(RR-5):1-22; quiz CE1-7. PubMed ID: 15580728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polio vaccines, eradication and posterradication].
    Salmerón García F; Portela Moreira A; Soler Soneira M; López Hernández S; Chamorro Somoza Díaz-Sarmiento M; Pérez González I; Rubio Gómez MI; Pérez González A; Sagredo Rodríguez A; Ruiz Antúnez S; Timón Jiménez M; Frutos Cabanillas G
    Rev Esp Salud Publica; 2013; 87(5):497-505. PubMed ID: 24322286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of trivalent oral poliomyelitis vaccine: a case-control study.
    Deivanayagam N; Nedunchelian K; Ahamed SS; Rathnam SR
    Bull World Health Organ; 1993; 71(3-4):307-9. PubMed ID: 8324848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress toward poliomyelitis eradication--Egypt, 1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Apr; 43(12):223-6. PubMed ID: 8127328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cluster survey evaluation of coverage and risk factors for failure to be immunized during the 1995 National Immunization Days in Egypt.
    Reichler MR; Darwish A; Stroh G; Stevenson J; Al Nasr MA; Oun SA; Wahdan MH
    Int J Epidemiol; 1998 Dec; 27(6):1083-9. PubMed ID: 10024208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
    Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A
    Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polio eradication: the OPV paradox.
    Dowdle WR; De Gourville E; Kew OM; Pallansch MA; Wood DJ
    Rev Med Virol; 2003; 13(5):277-91. PubMed ID: 12931339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward poliomyelitis eradication--India, December 1995 and January 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 May; 45(18):370-3. PubMed ID: 8606686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polio eradication--target 2000.
    Gomber S; Agarwal KN
    Indian J Pediatr; 1996; 63(4):477-83. PubMed ID: 10832468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards global poliomyelitis eradication: the successes and challenges for a developed country.
    Wood N; Thorley B
    J Paediatr Child Health; 2003 Dec; 39(9):647-50. PubMed ID: 14629492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of poliomyelitis in the United States.
    Nathanson N
    Rev Infect Dis; 1982; 4(5):940-50. PubMed ID: 7146731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.